Priporočila za preprečevanje in zdravljenje slabosti in bruhanja ob sistemskem onkološkem zdravljenju
Recommendations for prevention and treatment of nausea and vomiting in systemic oncology treatment

  • Martina Reberšek Onkološki inštitut, Ljubljana
  • Nežka Hribernik Onkološki inštitut, Ljubljana
Keywords: nausea, vomiting, oncological patients, systemic treatment

Abstract

Ni abstrakta.

Abstract (Eng)

In spite of great advancement, nausea and vomiting remain the most common undesirable effects of systemic cancer treatment, which substantially lower the patients’ quality of life and reduce their compliance to continue systemic treatment. Recommendations for prevention and treatment of nausea and vomiting resulting from cytostatic treatment were published in 2003 in Oncology magazine. This article complements the recommendations for treatment of nausea and vomiting with new developments, which were published in the NCCN guidelines in 2014 and MASCC and ESMO in 2010 (1, 2). We present our method for treating dysphagia with the help of intraluminal oesophageal stents. In our practice, the intraluminal oesophageal stent has proven to be a very effective and the most patient-friendly method for optimal delivery of nutrients before and during neoadjuvant therapy. There are few complications, and insertions do not have a negative impact on the perioperative outcomes.
Published
2014-12-15
How to Cite
Reberšek, M., & Hribernik, N. (2014). Recommendations for prevention and treatment of nausea and vomiting in systemic oncology treatment. Onkologija : A Medical-Scientific Journal, 18(2), 105-107. Retrieved from https://revijaonkologija.si/Onkologija/article/view/124
Section
Guidelines
Page
105-107